ArticleCPT: pharmacometrics & systems pharmacology2022

Tumor growth inhibition modeling to support the starting dose for dacomitinib.

Luke K Fostvedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.